NEW YORK, Jan. 21 - GenoMed on Friday said it has signed a Letter of Intent with the DW Coordinating Center to buy 50 Caucasian samples of "common, serious diseases."

DWCC, a global contract-research group with research ties to Eastern Europe based in Los Altos, Calif., will obtain blood samples from patients with "common diseases" like hypertension, myocardial infarction, stroke, and some cancers.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.